BlackRock, Inc.

Position in ATYR — aTYR PHARMA INC

CIK 2012383 New York, NY

Position in ATYR

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,090,914

-$3,935,328 QoQ

Shares Held

1,827,332

-71.6% QoQ

Ownership

1.86%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 90 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. ATYR ranks #326 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,029,867	1,725,072	—	Shares	Sole	2026-07-27
2026-06-30	$1,090,914	1,827,332	-71.6%	Shares	Sole	2026-08-07
2026-03-31	$5,026,242	6,443,904	-1.6%	Shares	Sole	2026-05-13
2025-12-31	$5,128,410	6,549,699	+1.2%	Shares	Sole	2026-02-12
2025-09-30	$4,667,668	6,473,884	+12.0%	Shares	Sole	2025-11-12
2025-06-30	$29,317,947	5,782,633	+262.8%	Shares	Sole	2025-08-12
2025-03-31	$4,813,820	1,593,981	+4.5%	Shares	Sole	2025-05-02
2024-12-31	$5,520,906	1,525,113	+9.2%	Shares	Sole	2025-02-07
2024-09-30	$2,457,948	1,396,562	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.